Skip to main content
. 2023 Aug 18;129(7):1152–1165. doi: 10.1038/s41416-023-02387-8

Table 7.

Leukaemia relative risks in other groups exposed to ionising radiation in childhood and adulthood.

Cohort Endpoint RR at 1 Gy ( + 95% CI)
Childhood exposure—present study and other childhood exposed at low-dose rate
  Present study AML 4.91 (2.63, 8.99)
CML 7.21 (3.17, 15.89)
ALL 24.45 (9.64, 73.28)
  UK background radiation [45] AML 41 (0, 211)
All leukaemia 91 (21, 171)
  Swiss background radiation [46] All leukaemia 37 (0, 78)
  French background radiation [49] Acute leukaemia 1 (0, 11)
  French background radiation [50] ALL 0 (0, 9)
AML 0 (0, 17)
  Finnish background radiation [51] ALL 0 (0, 91)
AML 0 (0, 151)
  Chernobyl exposure age <6 [52] All leukaemia 33.4 (9.78, 85.0)
Childhood exposure—high-dose rate
  LESG childhood cancer [53, 54] All leukaemia 1.00 (0.97, 1.09)
  UK childhood cancer [54, 55] All leukaemia 1.24 (1.01, 2.28)
  Euro2K childhood cancer [56] All leukaemia 1.31 (0.68, 1.94)
  SFOP childhood cancer [57] All leukaemia 0.99 (0.93, 1.04)
  Pooled childhood cancer [40] All leukaemia without chemotherapy 2.55 (1.14, 15.3)
All leukaemia with chemotherapy 1.02 (0.99, 1.09)
All-age exposure low-dose rate
  Indian background radiation [58] Leukaemia excluding CLL 6.84 (ND, 345.3)
  Chinese background radiation [59] All leukaemia 11.68 ( < 0, ∞)
  Techa River [60] Chronic myeloid leukaemia 4.1 (1.5, 19)
Leukaemia excluding CLL 1.51 (1.17, 2.5)
Acute/subacute leukaemia 2.8 (1.4, 6.9)
  Taiwan 60Co [61] Leukaemia excluding CLL 2.8 (1.4a, 3.8a)
All-age exposure high-dose rate
  LSS + IRSCC + UK Spondylitis [36] AML 4.60b
CML 3.26b
Adult low-dose-rate exposure
  INWORKS [37] AML 2.29 (0.18a, 5.28a)
CML 11.45 (5.48a, 20.65a)
ALL 6.80 (NA, 32.57a)
  Mayak [62] AML 14.23 (5.25a, 49.45a)
CML 2.39 (0.78a, 8.32a)
  Chornobyl clean-up [63] Leukaemia excluding CLL 6.0 (0.0a, 58a)
  Chornobyl clean-up [64] Leukaemia excluding CLL 3.21 (1.05, 8.61)
  Chornobyl clean-up [65] Leukaemia excluding CLL 1.44 (0.00a, 3.56a)

LESG Late Effects Study Group, SFOP Société Française d’Oncologie Pédiatrique, IRSCC International Radiation Study of Cervical Cancer patients, INWORKS International Nuclear Workers Study.

a90% CI.

bAdjusted to age at exposure 25 years, 25 years since exposure; quadratic-exponential relative risk model RR shown at 1 Gy.